Comprehensive evaluation of the clinical feasibility of using perinatal medical waste as a source for fetal mesenchymal stem cell banking under good manufacturing practice conditions
- 24 November 2025
- journal article
- research article
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 27 (1) , 1
Abstract
This study aimed to determine the most feasible perinatal tissue for Good Manufacturing Practice (GMP)-compliant banking of mesenchymal stromal-like cells (MSC-like cells). It was hypothesized that amniotic fluid collected during cesarean section would yield lower contamination rates and greater processing feasibility compared with other perinatal tissues. This prospective observational study was conducted at a tertiary university hospital and included 32 healthy term pregnancies. A total of 160 perinatal samples—amniotic fluid, amniotic membrane, umbilical cord, intact placenta, and placental fragments—were obtained. A validated feasibility scoring system evaluated material acquisition difficulty, transportation logistics, storage duration, and processing complexity. Samples were stratified by delivery mode (cesarean section vs. vaginal delivery) and collection timing (within vs. outside laboratory working hours). Stem cell isolation, sterility assessment, and immunophenotypic characterization were performed. Due to the absence of trilineage differentiation assays and maternal–fetal origin confirmation, the isolated cells were defined as MSC-like cells rather than definitive fetal MSCs. Statistical analyses were performed using chi-square and Mann–Whitney U tests (p < 0.05). Samples collected via cesarean section demonstrated significantly lower rates of blood contamination (25.8% vs. 60.0%, p < 0.001) and bacterial contamination (25.8% vs. 60.0%, p < 0.001) compared with those from vaginal deliveries. Amniotic fluid achieved the highest acquisition score, required no enzymatic digestion, and had the shortest median isolation time (45 min). It exhibited the lowest overall contamination and was the most suitable source for GMP-oriented MSC-like cell processing. Conversely, intact placenta and placental fragments showed the highest contamination rates, longest enzymatic processing times, and greatest logistical burden. While collection timing affected storage duration and workflow continuity, tissue type and delivery mode were the dominant determinants of feasibility. Cesarean section-derived amniotic fluid appears to be the most practical, sterile, and processing-efficient perinatal source for GMP-adapted MSC-like cell banking within the evaluated parameters. These results support its prioritization in the development of standardized collection and processing protocols for perinatal stromal cell applications in regenerative medicine.Keywords
This publication has 18 references indexed in Scilit:
- Multipotent fetal stem cells in reproductive biology researchStem Cell Research & Therapy, 2023
- Contamination Rate of Cryopreserved Umbilical Cord Blood Is Inversely Correlated with Volume of Sample Collected and Is also Dependent on Delivery ModeStem Cells Translational Medicine, 2022
- Placental Tissues as Biomaterials in Regenerative MedicineBioMed Research International, 2022
- Deep microbial analysis of multiple placentas shows no evidence for a placental microbiomeBJOG: An International Journal of Obstetrics & Gynaecology, 2019
- Optimal Stem Cell Transporting Conditions to Maintain Cell Viability and CharacteristicsTissue Engineering and Regenerative Medicine, 2018
- Isolation of human mesenchymal stem cells from amnion, chorion, placental decidua and umbilical cord: comparison of four enzymatic protocolsBiotechnology Letters, 2018
- Avoidance of Maternal Cell Contamination and Overgrowth in Isolating Fetal Chorionic Villi Mesenchymal Stem Cells from Human Term PlacentaStem Cells Translational Medicine, 2017
- Bacterial contamination of amniotic membrane in a tissue bank from IranCell and Tissue Banking, 2012
- Comparison of Human Placenta- and Bone Marrow–Derived Multipotent Mesenchymal Stem CellsStem Cells and Development, 2008
- Effect of holding time, temperature and different parenteral solutions on viability and functionality of adult bone marrow-derived mesenchymal stem cells before transplantationJournal of Tissue Engineering and Regenerative Medicine, 2008